National Institute of Neurological Disorders and Stroke; Notice of Meeting, 42969 [2013-17188]
Download as PDF
Federal Register / Vol. 78, No. 138 / Thursday, July 18, 2013 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 12, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17187 Filed 7–17–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Muscular Dystrophy Coordinating
Committee (MDCC).
The meeting will be open to the
public and accessible by live webcast.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Type of Meeting: Open Meeting.
Date: August 26, 2013.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The purpose of this meeting is to
bring together the committee members to
update one another on individual agency
efforts, to discuss planning for revision of the
Action Plan for the Muscular Dystrophies,
and to discuss two issues affecting all types
of muscular dystrophy: (a) Transitions to
adulthood, career, and independence for
individuals with muscular dystrophy and (b)
therapeutic misconception in clinical trials.
An agenda is posted to the MDCC Web site:
https://www.ninds.nih.gov/find_people/
groups/mdcc/index.htm.
Registration: To register, please go to:
https://meetings.ninds.nih.gov/meetings/
2013_MDCC_Meeting/.
Webcast Live: For those not able to attend
in person, this meeting will be webcast at:
https://videocast.nih.gov/.
Place: Neuroscience Center, 6001
Executive Boulevard, Conference Room A1/
A2, Rockville, Maryland 20852–1699.
Contact Person: John D. Porter, Ph.D.,
Executive Secretary, Muscular Dystrophy
Coordinating Committee, National Institute
of Neurological Disorders and Stroke, NIH,
6001 Executive Boulevard, NSC 2172,
Bethesda, MD 20892, (301) 496–5739,
porterjo@ninds.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
VerDate Mar<15>2010
17:20 Jul 17, 2013
Jkt 229001
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Attendance is limited to seating space
available. Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other reasonable
accommodations, should inform the Contact
Person listed below in advance of the
meeting.
All visitors must go through a security
check at the Lobby of the Neuroscience
Center (NSC) building to receive a visitor’s
badge. A government issued photo ID is
required.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: July 11, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17188 Filed 7–17–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;, Molecular
and Cellular Neuroscience.
Date: July 29, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00042
Fmt 4703
Sfmt 9990
42969
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard D Crosland, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, rc218u@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Genetics of
Cell Regulation.
Date: August 1, 2013.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7804, Bethesda, MD 20892, 301–435–
1779, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Continuous
Submission Panel.
Date: August 6, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mike Radtke, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176,
MSC 7806, Bethesda, MD 20892, 301–435–
1728, radtkem@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Shared
Instrumentation: PET/CT/SPECT.
Date: August 6, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Malgorzata Klosek, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7849, Bethesda, MD 20892, (301) 435–
2211, klosekm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: July 11, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17190 Filed 7–17–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\18JYN1.SGM
18JYN1
Agencies
[Federal Register Volume 78, Number 138 (Thursday, July 18, 2013)]
[Notices]
[Page 42969]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17188]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Muscular Dystrophy Coordinating Committee (MDCC).
The meeting will be open to the public and accessible by live
webcast.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Type of Meeting: Open Meeting.
Date: August 26, 2013.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end
time.
Agenda: The purpose of this meeting is to bring together the
committee members to update one another on individual agency
efforts, to discuss planning for revision of the Action Plan for the
Muscular Dystrophies, and to discuss two issues affecting all types
of muscular dystrophy: (a) Transitions to adulthood, career, and
independence for individuals with muscular dystrophy and (b)
therapeutic misconception in clinical trials.
An agenda is posted to the MDCC Web site: https://www.ninds.nih.gov/find_people/groups/mdcc/index.htm.
Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/2013_MDCC_Meeting/.
Webcast Live: For those not able to attend in person, this
meeting will be webcast at: https://videocast.nih.gov/.
Place: Neuroscience Center, 6001 Executive Boulevard, Conference
Room A1/A2, Rockville, Maryland 20852-1699.
Contact Person: John D. Porter, Ph.D., Executive Secretary,
Muscular Dystrophy Coordinating Committee, National Institute of
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard,
NSC 2172, Bethesda, MD 20892, (301) 496-5739,
porterjo@ninds.nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Attendance is limited to seating space available. Individuals
who plan to attend and need special assistance, such as sign
language interpretation or other reasonable accommodations, should
inform the Contact Person listed below in advance of the meeting.
All visitors must go through a security check at the Lobby of
the Neuroscience Center (NSC) building to receive a visitor's badge.
A government issued photo ID is required.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: July 11, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-17188 Filed 7-17-13; 8:45 am]
BILLING CODE 4140-01-P